Grzegorz H. Bręborowicz

Grzegorz H. Bręborowicz

Auto-generated profile, based on publicly available information

Grzegorz H. Bręborowicz

Department of Perinatology and Gynecology, Poznan University of Medical Sciences, 33 Polna Street, Poznań 60-535, Poland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Closed access
ASAgata Szpera
Agata Szpera
GBGrzegorz H Breborowicz
Grzegorz H Breborowicz
There are many theories regarding the ultimate cause of pre-eclampsia, and nowadays it is thought that the mechanism of pathogenesis is most likely multifactorial. The pathophysiology probably involves both fetal or placental and maternal factors. The most likely relevant factors in the pathogenesis are the abnormal development of the placenta, systemic endothelial dysfunction or cell activation, and an imbalance between pro-angiogenic and anti-angiogenic proteins with a predominance of antiangiogenic factors. In women with pre-eclampsia, placental tissue overproduces two main anti-angiogenic proteins which enter into the maternal circulation: soluble Fmssuch as tyrosine kinase 1 (sFlt1 or sVEGFR1) and soluble endoglin (sEng). Moreover, these patients have low circulating blood levels of two pro-angiogenic peptides: placental growth factor (PlGF) and vascular endothelial growth factor (VEGF). Adequate levels of CECs (circulating endothelial cells), EPCs (endothelial progenitor cells) and microparticles most likely play an important part in the development and regulation of vascularization in pregnancy but the exact role of these cells and micropatticles in the pathogenesis of pre-eclampsia is unknown. Some imbalances in these levels are associated with endothelial insufficiency.

1 June 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Katarzyna Kosicka-NoworzyńKatarzyna Kosicka-Noworzyń
Katarzyna Kosicka-Noworzyń
ASAnna Siemiątkowska
Anna Siemiątkowska
DPDąbrówka Pałka
Dąbrówka Pałka
ASAgata Szpera
Agata Szpera
GBGrzegorz H. Bręborowicz
Grzegorz H. Bręborowicz
Franciszek GłówkaFranciszek Główka
Franciszek Główka

14 February 2013 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
PDF file
GBGrzegorz H. Bręborowicz
Grzegorz H. Bręborowicz
WMWiesław Markwitz
Wiesław Markwitz
MGMichał Gaca
Michał Gaca
AKAgnieszka Koziołek
Agnieszka Koziołek
MRMariola Ropacka-Lesiak
Mariola Ropacka-Lesiak
MKMariola Krzyścin
Mariola Krzyścin
Objective: Abnormal implantation of placenta previa is life-threatening condition. The purpose of this study was to evaluate the impact of the conservative management of pregnancies with such complication on maternal morbidity rate and the chance for uterine preservation (fertility). Methods: Eleven patients with abnormal implantation of placenta previa were analyzed prospectively. This complication was diagnosed antenatally by two-dimensional ultrasound and color flow Doppler. The following outcomes were analyzed: need for blood transfusion, admission and duration of stay in intensive care unit, infections, coagulopathies, time between cesarean section and delivery of placenta, hysterectomy and preservation of uterus. Results: Among the 20 085 women who had a singleton gestation, 11 (0.054%) were identified with placenta previa with abnormal placentation. In five patients (group A), hysterectomy was performed because of hemorrhage or placenta ablation. In six patients (group B), conservative management succeeded and placenta were preserved. In group A, placenta were delivered earlier (2 d–8 weeks) in comparison with group B (6–15 weeks). Estimated blood loss during the delayed delivery of placenta was higher in the group with hysterectomy (respectively, 450–1600 and 300–500 ml). Conclusions: Conservative management of placenta previa with abnormal implantation decreases the risk of severe hemorrhage at the time of delivery and can preserve fertility.